(Worthy News) – Pharmaceutical company Moderna indicated this week that it had sent the U.S. government a “catch-up” payment of $400 million in connection with a patent dispute.
The company concluded an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) in December of last year, establishing “a nonexclusive patent license agreement” allowing the company to use disputed technologies in its production of the COVID-19 vaccine, the Epoch Times reported.
In addition to the $400 million payment to NIAID, Moderna will “pay low single-digit royalties on future net sales of our COVID-19 vaccines,” according to Moderna CFO Jamey Mock. [ Source: Just the News (Read More…) ]
We're being CENSORED ... HELP get the WORD OUT! SHARE!!!
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.